Explanation
Adatimumab
Failuretocontrotsymptomsafter twodifferentnon-steroidaL anti-inflammatory dmugs NSADs) isan indication
forinterventic
ithabiologicalagent in ankylosing spondylitis.Elevated umour necrosisfactor (TNF)-alpha
levesareclosety associatedwithankylosingspondyLitisdisease activity. and etanerceptor adalimumabare
both potentiauoptions.
@1MINENDOCRINE
